This study tested a new treatment called STMC-103H in 283 newborn babies and infants who are at high risk for developing allergies (like eczema or food allergies) because of their family history. The goal was to see if the treatment is safe and can prevent these allergic conditio…
Phase: PHASE1, PHASE2 • Sponsor: Siolta Therapeutics, Inc. • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC